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Background: Although drug-eluting stents (DES) decrease restenosis, concerns about stent thrombosis have limited DES use. Bare-metal stents 
(BMS) are frequently used in patients who are at high risk for bleeding, noncompliant, need impending surgery or have complex coronary anatomy 
precluding DES delivery. These variables are not incorporated into percutaneous coronary intervention (PCI) mortality risk models. Although BMS 
are associated with higher mortality after hospital discharge, little is known about in-hospital outcomes in patients treated with BMS and balloon 
angioplasty alone (BAA).
Methods: This study analyzed 11,951 consecutive patients who underwent PCI at 11 facilities during 2008-09. Risk-adjusted mortality was 
assessed by both the ACC-NCDR and Clinical Outcomes Assessment Program (COAP) PCI risk models. A logistic regression was performed with the risk 
scores and PCI type as the independent predictors.
Results: The volumes, observed and predicted mortalities, O/E ratios, and odds ratios from the logistic regression by PCI group are presented in 
Table 1. The O/E ratios and odds ratios for BAA and BMS were much higher than DES, and stent type was a significant independent predictor of 
mortality.
Conclusions: Patients receiving BMS or BAA are higher risk patients for mortality. The choice of BMS or BAA independently affects the risk of 
mortality, presumably due to unmeasured confounding variables. PCI risk models should incorporate stent type into PCI mortality risk adjustment.
Table 1. Mortality by PCI group
DES BMS DES & BMS BAA
N (%) 7517 (63%) 3021 (25%) 457 (4%) 956 (8%)
Observed Mortality (%) 0.8 2.4 1.8 5.1
Predicted Mortality (%) COAP Model 1.3 2.3 1.8 3.1
Predicted Mortality (%)ACC Model 0.8 1.7 0.8 2.6
O/E Mortality Ratio COAP Model 0.6 1.1 1.0 1.7
O/E Mortality Ratio ACC Model 1.0 1.4 2.1 2.0
Odds Ratio in Logistic Regression
With COAP Risk Score 1.0(Reference)
1.83
(1.26, 2.66)
3.77
(2.42, 5.86)
2.34
(1.05, 5.22)
With ACC Risk Score 1.0(Reference)
1.89
(1.30, 2.74)
3.64
(2.23, 5.67)
1.63
(0.72, 3.68)
